Bill > SF3306

This bill modifies prior authorization requirements for health insurance in Minnesota, focusing on three key areas related to medical treatments. First, the bill prohibits prior authorization for antineoplastic (cancer) treatments that align with national cancer treatment guidelines, removing previous medication-specific authorization requirements. Second, the bill mandates that health insurers must accept and review prior authorization requests submitted within seven days of a healthcare service being provided, preventing denials based solely on timing. Third, the bill requires insurers to create an automated prior authorization application programming interface (API) by January 1, 2027, which will allow healthcare providers to electronically determine authorization requirements and submit requests. Additionally, the bill introduces a provision that expedites prior authorization reviews for medications that have been previously authorized or covered for a patient, ensuring continuity of care. The legislation applies to health benefit plans offered or renewed on or after specified dates and aims to streamline and simplify the prior authorization process for healthcare providers and patients, particularly those receiving cancer treatments and ongoing medication regimens.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3306&ssn=0&y=2025